Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway

Adv Drug Deliv Rev. 2024 Apr:207:115196. doi: 10.1016/j.addr.2024.115196. Epub 2024 Feb 7.

Abstract

Intranasal delivery provides a direct and non-invasive method for drugs to reach the central nervous system. Nanoparticles play a crucial role as carriers in augmenting the efficacy of brain delivery. However, the interaction between nanoparticles and the nose-to-brain pathway and how the various biopharmaceutical factors affect brain delivery efficacy remains unclear. In this review, we comprehensively summarized the anatomical and physiological characteristics of the nose-to-brain pathway and the obstacles that hinder brain delivery. We then outlined the interaction between nanoparticles and this pathway and reviewed the biomedical applications of various nanoparticulate drug delivery systems for nose-to-brain drug delivery. This review aims at inspiring innovative approaches for enhancing the effectiveness of nose-to-brain drug delivery in the treatment of different brain disorders.

Keywords: Biomimetic drug delivery systems; Intranasal drug delivery; Neurodegenerative diseases; Nose-to-brain pathway; Synthesized drug delivery systems; Target drug delivery.

Publication types

  • Review

MeSH terms

  • Administration, Intranasal
  • Brain* / metabolism
  • Drug Delivery Systems / methods
  • Humans
  • Nanoparticles* / metabolism
  • Pharmaceutical Preparations / metabolism

Substances

  • Pharmaceutical Preparations